Hematologic Malignancies
📧 Sign up to get email alerts when something new happens for Hematologic Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation [Phase 1]
This clinical trial update reports the completion of a Phase I study evaluating the infusion of selected donor natural killer (NK) cells aft…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis [Phase 2, Phase 3]
A clinical trial update notes that luspatercept is being evaluated in Phase 2/Phase 3 studies to prevent poor erythroid engraftment in patie…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors [Phase 1]
A first-in-human Phase 1 study evaluating the safety and tolerability of VVD-130850 in participants with advanced solid tumors and advanced …
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California [NA]
This clinical trial entry describes a culturally informed patient navigation program aimed at reducing delays from diagnosis to treatment fo…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow Chamber
A completed clinical trial evaluating the impact of mindfulness meditation training on anxiety and sleep quality in patients undergoing hema…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: The Effect of Relaxation Breathing Exercise on Chemotherapy Induced Nausea and Vomiting [NA]
This clinical trial update describes evaluating relaxation breathing exercises to reduce chemotherapy-induced nausea and vomiting in patient…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Exercise in Patients Undergoing Autologous Stem Cell Transplantation: A Randomized Controlled Trial [NA]
A completed randomized controlled trial evaluating exercise in patients undergoing autologous hematopoietic stem cell transplantation for he…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
A single-center comparative analysis from China assessing how the burden of mucormycosis evolves in patients with hematologic malignancies d…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating reduced-intensity, partially HLA-mismatched bone marrow transplantation for hematologic malignancies; the study i…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies [NA]
The study evaluated an inpatient advance care planning intervention for older patients with hematologic malignancies; the trial is completed…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors [NA]
A completed clinical trial evaluating attention bias modification to reduce anxiety in adolescent and young adult cancer survivors.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity [Phase 2]
A Phase 2 trial evaluated a two-step approach to allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancie…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection [EARLY_Phase 1]
An exploratory early-phase study evaluating WGb-0302 injections for recurrent and refractory hematologic malignancies. The trial is not yet …
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients [Phase 1, Phase 2]
This clinical trial update reports termination and posted results for a Phase 1/2 study of rintatolimod plus interferon alpha-2b in cancer p…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer [EARLY_Phase 1]
This early-phase trial update outlines a Phase 1 study evaluating whole-body MRI and liquid biopsy for early cancer detection in people with…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome [Phase 4]
Phase 4 clinical trial update examining pegloticase for lowering uric acid in patients with tumor lysis syndrome; the study is active but no…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: M-2018-334 in Hematological Malignancies [NA]
A Miltenyi Biomedicine-sponsored clinical trial (NCT06225050) evaluating an investigational product for hematologic malignancies is not yet …
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Phase I Study of BR108 in Hematological Malignancies [Phase 1]
A Phase I study of BR108 in hematologic malignancies has been terminated, with no further trial activity reported.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)
A clinical trial examining immunoregulatory T lymphocyte subtypes in the context of allogeneic hematopoietic stem cell transplantation for h…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients
A completed clinical trial evaluated protein A immunoadsorption in highly sensitized haploidentical hematopoietic stem cell transplant patie…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant [NA]
An update on an ongoing clinical trial evaluating a mobile CARE-App to help caregivers cope during stem cell transplantation for hematologic…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies [Phase 2]
Phase 2 study of haploidentical bone marrow transplantation for hematologic malignancies was terminated, with results posted on 2025-11-10.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Remote Monitoring in Cancer Care: A Platform Study
Completed results of a Mayo Clinic platform study evaluating remote monitoring in cancer care across head and neck cancer, hematologic malig…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease [Phase 1]
GRAVITAS-119, a Phase 1 study evaluating itacitinib with calcineurin inhibitor-based interventions for prophylaxis of graft-versus-host dise…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes [Phase 1]
Phase 1 pharmacokinetic study update characterizes belinostat exposure across patients with different UGT1A1*28 genotypes (wild-type, hetero…